ACTRN12613001207707已完成未知
Pilot Study for a trial in Human Papillomavirus (HPV) vaccinated and unvaccinated women presenting for cervical screening of 6 yearly HPV screening versus 3-yearly cytology screening to assess the feasibility via recruitment rates, cross sectional positivity rate and laboratory implementation.
Roche Molecular Systems Inc. and0 个研究点目标入组 5,001 人开始时间: 2013年11月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5,001
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 25 Years 至 64 Years（—）
- 性别
- Female
入选标准
- •Australian female resident of Victoria
- •Aged 25-64
- •Attending for routine cervical screening at a participating health care practice
排除标准
- •Total hysterectomy (uterus and cervix)
- •Presence of symptoms for which cervical cancer must be excluded
- •Currently undergoing treatment for cervical pre-cancer, or cancer
- •Attending for follow-up of a prior cervical abnormality, including repeated test of cure procedures in which the woman has not yet been discharged back to routine screening
- •Known pregnancy
研究者
相似试验
已完成
不适用
The Canadian Cervical Cancer Screening Trial of human papillomavirus (HPV) testing versus Pap cytologyCancerISRCTN57612064McGill University (Canada) - Research Grants Office10,154
已完成
3 期
Safety and Tolerability Study of V501 in Japanese Boys (V501-200)Anogenital Human Papilloma Virus InfectionCondyloma AcuminataNCT02576054Merck Sharp & Dohme LLC101
尚未招募
不适用
To find out presence of Human Papillomavirus(HPV) infection and HPV-related diseases in HIV-positive men who have sex with other meCTRI/2022/09/045981Department of Health Research
已完成
不适用
A randomised trial of human papillomavirus (HPV) testing in primary cervical screeningCervical cancerMalignant neoplasm of cervix uteriCancerISRCTN25417821niversity of Manchester (UK)24,510
Enrolling By Invitation
不适用
Evaluation of a voluntary human papillomavirus (HPV) vaccination in school for girls aged 9 and older in the Rhine-Neckar metropolitan regioWillingness to use the HPV vaccination for girls aged 9 years or overDRKS00011814Gesundheitsnetz Rhein-Neckar e.V.560